Hikma Pharmaceutical | HIK - Assets


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Hikma Pharmaceutical

Hikma Pharmaceutical reported $4.47B in Assets for its fiscal semester ending in December of 2022.


Assets Change
Almirall SA ALM:SM EUR 2.15B 7.52M
Artemis Alpha ATS:LN GBP 111.08M 18.39M
AstraZeneca AZN:LN USD 96.69B 204M
Bayer BAYN:GR EUR 125.05B 175M
Fresenius FRE:GR EUR 76.55B 138M
Galapagos GLPG:NA EUR 4.63B 102.18M
Genmab GEN:DC DKK 30.39B 116M
GlaxoSmithKline GSK:LN GBP 58.6B 1.55B
Hikma Pharmaceutical HIK:LN USD 4.47B 276M
Lonza Group LONN:SW CHF 17.36B 613M
Merck MRK:GR EUR 48.64B 111M
Orion ORNBV:FH EUR 1.29B 211.3M
Recordati REC:IM EUR 3.98B 16.75M
Roche Holding ROG:VX CHF 88.15B 1.42B
UCB UCB:BB 15.87B 440M